AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Investor AB

Share Issue/Capital Change • Mar 6, 2013

2931_rns_2013-03-06_8c8e70ee-202e-4e8e-8166-ca1cff8967e2.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Press release

Stockholm, March 6, 2013

Investor subscribes for SEK 270 m. in a directed new issue in Active Biotech

Investor has entered into an agreement to subscribe for SEK 270 m. in a directed new issue in Active Biotech, paying SEK 45 per share for 6.0 m. shares. Investor's ownership will amount to 8.0 percent of the capital and votes. The holding in Active Biotech will be reported within Financial Investments.

For further information:

Magnus Dalhammar, Investor Relations Manager, Phone +46 8 614 2130, +46 735 24 2130

Our press releases can be accessed at www.investorab.com

Founded by the Wallenberg family a hundred years ago, Investor is the leading owner of high quality Nordic-based international companies. Through board participation, our industrial experience, network and financial strength, we strive to make our companies best-in-class. Our holdings include Atlas Copco, ABB, Ericsson and Mölnlycke Health Care.